Stent System Secured European Regulatory Approval
Patients and clinicians in Europe retain access to this heart treatment technology under new safety standards.
Updated on Sept. 29, 2026 in Heart Disease
Live Poll
Do you support strict regulatory requirements for medical devices even if they increase manufacturing costs?
Sahajanand Medical Technologies has received certification under the European Union Medical Device Regulation for its Supraflex Cruz stent system. This approval confirms that the coronary vessel treatment meets current safety and clinical performance requirements for continued use in European markets.
Why it matters
Securing this certification ensures that the device remains available for clinicians and patients treating occluded or stenosed coronary vessels across Europe. The rigorous process validates the clinical evidence and quality management systems behind this widespread cardiac intervention.
The certification is grounded in extensive clinical evidence, including data from 5,000 participants in four randomized controlled trials and 13,000 patients in seven real-world registries. These findings confirm the device's performance in treating coronary vessel disease.
The players
Sahajanand Medical Technologies
A Mumbai-based medical device manufacturer specializing in cardiovascular intervention products like drug-eluting stents.
The details
The Supraflex Cruz is a sirolimus-eluting coronary stent system designed to keep narrowed or blocked heart arteries open. The regulatory approval process required a comprehensive conformity assessment, which analyzed the company's technical documentation, clinical trial results, and quality management systems to verify the device's safety and effectiveness. This ensures the mechanical and biological components of the stent meet the strict European safety standards for invasive cardiac procedures.
Timeline
September 29, 2026: The company announced receipt of the EU MDR certification.
Health Landscape
This certification aligns the Supraflex Cruz system with the requirements of the European Union Medical Device Regulation 2017/745. It represents a significant shift as manufacturers work to re-verify existing medical technologies against the region's current, more rigorous safety standards.
Patients with coronary artery disease should consult their cardiologist regarding the specific types of stents available for their procedure. Questions about the safety profile or clinical history of a device used in your care are always appropriate to raise with your physician.
The takeaway
This certification confirms that the Supraflex Cruz system meets modern European safety and performance standards for treating coronary artery disease. Patients should always discuss the selection of specific medical devices with their interventional cardiologist to understand the benefits for their care.
Further reading
For more information on how current medical technologies are evaluated, visit our Heart Disease section.
Source note: This article includes information reported by ETHealthworld.
Live Poll
Do you support strict regulatory requirements for medical devices even if they increase manufacturing costs?
